Gland Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE068V01023
  • NSEID: GLAND
  • BSEID: 543245
INR
2,663.50
0.00 (0.00%)
BSENSE

Aug 10

BSE+NSE Vol: 7.43 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
1,800.27
1,742.79
1,695.36
1,486.88
1,505.62
1,424.91
1,384.05
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,800.27
1,742.79
1,695.36
1,486.88
1,505.62
1,424.91
1,384.05
Raw Material Cost
588.20
594.07
529.89
558.43
557.36
587.57
437.38
Purchase of Finished goods
1.95
2.28
1.50
1.94
0.88
3.10
2.15
(Increase) / Decrease In Stocks
34.18
-5.02
45.26
-6.56
-37.11
-102.71
23.18
Employee Cost
444.00
411.57
424.20
385.03
408.04
373.37
342.86
Power Cost
55.88
53.02
54.01
50.17
45.66
52.60
54.66
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
-0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
186.69
173.85
205.62
183.98
163.03
163.48
163.86
Total Expenditure (Excl Depreciation)
1,310.90
1,229.77
1,260.48
1,172.99
1,137.86
1,077.40
1,024.09
Operating Profit (PBDIT) excl Other Income
489.37
513.02
434.88
313.89
367.76
347.51
359.96
Other Income
61.23
111.47
63.17
84.16
57.53
44.03
58.49
Operating Profit (PBDIT)
550.60
624.49
498.05
398.05
425.29
391.54
418.45
Interest
4.36
10.03
3.93
7.82
11.50
7.45
22.82
Exceptional Items
0.00
0.00
-24.35
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
546.24
614.46
469.77
390.23
413.79
384.09
395.63
Depreciation
111.26
108.66
107.65
106.31
101.05
95.76
96.33
Profit Before Tax
434.98
505.80
362.13
283.92
312.74
288.33
299.30
Tax
118.02
139.12
100.65
100.23
97.26
101.79
94.61
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
316.96
366.68
261.48
183.68
215.48
186.54
204.69
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
316.96
366.68
261.48
183.68
215.48
186.54
204.69
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
316.96
366.68
261.48
183.68
215.48
186.54
204.69
Equity Capital
16.50
16.48
16.48
16.48
16.48
16.48
16.48
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
19.21
22.25
15.87
11.15
13.08
11.32
12.42
Diluted Earnings per share
19.22
22.23
15.87
11.15
13.08
11.32
12.42
Operating Profit Margin (Excl OI)
27.18%
29.44%
25.65%
21.11%
24.43%
24.39%
26.01%
Gross Profit Margin
30.34%
35.26%
27.71%
26.24%
27.48%
26.96%
28.58%
PAT Margin
17.61%
21.04%
15.42%
12.35%
14.31%
13.09%
14.79%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 3.30% vs 2.80% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is -13.56% vs 40.23% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is -4.61% vs 17.97% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is -56.53% vs 155.22% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

Compare Quarterly Results Of Gland Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,800.27
1,625.96
174.31
10.72%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,800.27
1,625.96
174.31
10.72%
Raw Material Cost
588.20
296.51
291.69
98.37%
Purchase of Finished goods
1.95
66.92
-64.97
-97.09%
(Increase) / Decrease In Stocks
34.18
-35.58
69.76
196.07%
Employee Cost
444.00
381.11
62.89
16.50%
Power Cost
55.88
0.00
55.88
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
186.69
493.42
-306.73
-62.16%
Total Expenditure (Excl Depreciation)
1,310.90
1,202.38
108.52
9.03%
Operating Profit (PBDIT) excl Other Income
489.37
423.58
65.79
15.53%
Other Income
61.23
70.90
-9.67
-13.64%
Operating Profit (PBDIT)
550.60
494.48
56.12
11.35%
Interest
4.36
3.18
1.18
37.11%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
546.24
491.30
54.94
11.18%
Depreciation
111.26
44.50
66.76
150.02%
Profit Before Tax
434.98
446.80
-11.82
-2.65%
Tax
118.02
112.58
5.44
4.83%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
316.96
334.22
-17.26
-5.16%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
316.96
334.22
-17.26
-5.16%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
316.96
334.22
-17.26
-5.16%
Equity Capital
16.50
25.07
-8.57
-34.18%
Face Value
1.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
19.21
26.66
-7.45
-27.94%
Diluted Earnings per share
19.22
26.72
-7.50
-28.07%
Operating Profit Margin (Excl OI)
27.18%
26.05%
0.00
1.13%
Gross Profit Margin
30.34%
30.22%
0.00
0.12%
PAT Margin
17.61%
20.56%
0.00
-2.95%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,800.27 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is 3.30% vs 2.80% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 19.57% vs 7.41% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 316.96 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -13.56% vs 40.23% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 47.09% vs 49.89% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 489.37 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -4.61% vs 17.97% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 33.07% vs 39.10% in Jun 2025

Quarterly - Interest
Interest 4.36 Cr
in Jun 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Jun 2026 is -56.53% vs 155.22% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -62.09% vs 104.63% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.18%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support.ra@mojomarkets.in, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."